LSV Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,400
| Closed | -$673K | – | 892 |
|
|
2023
Q2 | $673K | Hold |
22,400
| – | – | ﹤0.01% | 731 |
|
|
2023
Q1 | $812K | Sell |
22,400
-2,200
| -9% | -$79.8K | ﹤0.01% | 679 |
|
|
2022
Q4 | $877K | Hold |
24,600
| – | – | ﹤0.01% | 664 |
|
|
2022
Q3 | $833K | Sell |
24,600
-3,100
| -11% | -$105K | ﹤0.01% | 662 |
|
|
2022
Q2 | $801K | Hold |
27,700
| – | – | ﹤0.01% | 702 |
|
|
2022
Q1 | $895K | Sell |
27,700
-700
| -2% | -$22.6K | ﹤0.01% | 716 |
|
|
2021
Q4 | $828K | Sell |
28,400
-8,800
| -24% | -$257K | ﹤0.01% | 727 |
|
|
2021
Q3 | $992K | Sell |
37,200
-156,500
| -81% | -$4.17M | ﹤0.01% | 714 |
|
|
2021
Q2 | $5.96M | Sell |
193,700
-830,600
| -81% | -$25.6M | 0.01% | 528 |
|
|
2021
Q1 | $26.8M | Buy |
1,024,300
+2,400
| +0.2% | +$62.8K | 0.05% | 328 |
|
|
2020
Q4 | $25.7M | Buy |
1,021,900
+210,100
| +26% | +$5.29M | 0.05% | 331 |
|
|
2020
Q3 | $16.9M | Buy |
811,800
+115,434
| +17% | +$2.41M | 0.03% | 354 |
|
|
2020
Q2 | $16.5M | Sell |
696,366
-3,900
| -0.6% | -$92.6K | 0.03% | 371 |
|
|
2020
Q1 | $12.6M | Buy |
700,266
+8,900
| +1% | +$160K | 0.03% | 373 |
|
|
2019
Q4 | $16.4M | Buy |
691,366
+20,337
| +3% | +$482K | 0.03% | 412 |
|
|
2019
Q3 | $18.4M | Buy |
671,029
+650,329
| +3,142% | +$17.9M | 0.03% | 386 |
|
|
2019
Q2 | $684K | Buy |
+20,700
| New | +$684K | ﹤0.01% | 793 |
|